Consistent findings with NOAC plus aspirin in CAD and PAD with and without diabetes - PACE-CME

Consistent findings with NOAC plus aspirin in CAD and PAD with and without diabetes

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Use of ARNI in HFpEF patients reduces NT-proBNP levels
Use of ARNI in HFpEF patients reduces NT-proBNP levels
ACC 2020
Use of ARNI in HFpEF patients reduces NT-proBNP levels
- Jonathan Cunningham, MD
Reduced bleeding with P2Y12i monotherapy after 3 months DAPT after complex PCI
Reduced bleeding with P2Y12i monotherapy after 3 months DAPT after complex PCI
ACC 2020
Reduced bleeding with P2Y12i monotherapy after 3 months DAPT after complex PCI
- Prof. George Dangas, MD, PhD
Mechanistic underpinning of CV benefit observed with icosapent ethyl
Mechanistic underpinning of CV benefit observed with icosapent ethyl
ACC 2020
Mechanistic underpinning of CV benefit observed with icosapent ethyl
- Deepak Bhatt, MD
Added value of sGC stimulator in worsening HFrEF patients
Added value of sGC stimulator in worsening HFrEF patients
ACC 2020
Added value of sGC stimulator in worsening HFrEF patients
- Prof. Paul Armstrong, MD